{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T11:02:44Z","timestamp":1781002964890,"version":"3.54.1"},"reference-count":93,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T00:00:00Z","timestamp":1740528000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T00:00:00Z","timestamp":1740528000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"name":"Tier 1 Canada Research Chair"},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["274324"],"award-info":[{"award-number":["274324"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Mental Health Research Canada"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Psychopharmacol"],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>A sub-anesthetic dose of ketamine, an N-methyl-D-aspartate receptor (NMDAR) antagonist, produces robust antidepressant effects in treatment-resistant major depressive disorder (MDD). The mismatch negativity (MMN) is reliant on glutamatergic neurotransmission and reduced by NMDAR antagonists. The MMN may characterise the neural mechanisms underlying ketamine\u2019s effects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims:<\/jats:title>\n                    <jats:p>This study examined the acute effects of ketamine and midazolam on the MMN and its relationship to early and sustained decreases in depressive symptoms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      Treatment-resistant MDD patients (\n                      <jats:italic toggle=\"yes\">N<\/jats:italic>\n                      \u2009=\u200924), enrolled in a multi-phase clinical ketamine trial, received two intravenous infusions within an initial double-blind crossover phase: ketamine (0.5\u2009mg\/kg) and midazolam (30\u2009\u03bcg\/kg). Three recordings were carried out per session (pre-, immediately post- and 2\u2009h post-infusion). Peak MMN amplitude (\u03bcV), latency (ms), theta event-related oscillations (EROs), theta phase locking factor (PLF) and source-localised MMN generator activity were assessed. Relationships between changes in MMN indices and early (Phase 1: double-blind, cross-over phase) and sustained (Phases 2, 3: open-label repeated and maintenance phases, respectively) changes in depressive symptoms (Montgomery-\u00c5sberg Depression Rating Scale score) were examined.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Ketamine reduced frontal MMN amplitudes, theta ERO immediately post- and 2\u2009h post-infusion and source-localised peak MMN frontal generator activity. Select baseline and ketamine-induced MMN decreases correlated and predicted greater early (left frontal MMN decreases in amplitude and theta ERO, baseline left PLF) and sustained (baseline left PLF, right inferior temporal activity) symptom reductions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Acute NMDARs blockade reduced frontal MMN, with larger MMN reductions predicting greater symptom improvement. The MMN may serve as a non-invasive biomarker predicting antidepressant response to glutamatergic agents.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/02698811251319456","type":"journal-article","created":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T00:55:07Z","timestamp":1740617707000},"page":"577-592","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":3,"title":["Acute subanesthetic ketamine-induced effects on the mismatch negativity and their relationship to early and sustained treatment response in major depressive disorder"],"prefix":"10.1177","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1698-5938","authenticated-orcid":false,"given":"Sara","family":"de la Salle","sequence":"first","affiliation":[{"name":"University of Ottawa Institute of Mental Health Research at the Royal, Ottawa, ON, Canada"},{"name":"School of Psychology, University of Ottawa, Ottawa, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9635-8602","authenticated-orcid":false,"given":"Jennifer L","family":"Phillips","sequence":"additional","affiliation":[{"name":"University of Ottawa Institute of Mental Health Research at the Royal, Ottawa, ON, Canada"},{"name":"Department of Psychiatry, University of Ottawa, Ottawa, ON, Canada"},{"name":"Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Blier","sequence":"additional","affiliation":[{"name":"University of Ottawa Institute of Mental Health Research at the Royal, Ottawa, ON, Canada"},{"name":"Department of Psychiatry, University of Ottawa, Ottawa, ON, Canada"},{"name":"Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4969-3819","authenticated-orcid":false,"given":"Verner","family":"Knott","sequence":"additional","affiliation":[{"name":"University of Ottawa Institute of Mental Health Research at the Royal, Ottawa, ON, Canada"},{"name":"School of Psychology, University of Ottawa, Ottawa, ON, Canada"},{"name":"Department of Psychiatry, University of Ottawa, Ottawa, ON, Canada"},{"name":"Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,2,26]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2009.08.038"},{"key":"e_1_3_3_3_1","unstructured":"American Psychiatric Association (2000) Diagnostic and Statistical Manual of Mental Disorders 4th ed text revision (DSM-IV-TR). Washington DC: American Psychiatric Publishing."},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tics.2017.01.005"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2016.0011"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1177\/1550059420914200"},{"key":"e_1_3_3_7_1","first-page":"3","article-title":"Neural basis of major depressive disorder: Beyond monoamine hypothesis","volume":"37","author":"Boku S","year":"2018","unstructured":"Boku S, Nakagawa S, Toda H, et al. (2018) Neural basis of major depressive disorder: Beyond monoamine hypothesis. Comput Graph Forum 37: 3\u201312.","journal-title":"Comput Graph Forum"},{"key":"e_1_3_3_8_1","article-title":"Ketamine and other glutamate receptor modulators for depression in adults","volume":"9","author":"Caddy C","year":"2015","unstructured":"Caddy C, Amit BH, Mccloud TL, et al. (2015) Ketamine and other glutamate receptor modulators for depression in adults. Cochrane Database Syst Rev 9: CD011612.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/hup.2475"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1177\/0004867416631828"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2021.110507"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.00455"},{"key":"e_1_3_3_13_1","doi-asserted-by":"crossref","unstructured":"Duncan CC Barry RJ Connolly JF et al. (2009). Event-related potentials in clinical research: guidelines for eliciting recording and quantifying mismatch negativity P300 and N400. Clin Neurophysiol 120: 1883\u20131908.","DOI":"10.1016\/j.clinph.2009.07.045"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph17050639"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2020.00468"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-014-3664-5"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000000316"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2007.07.079"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbz027"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1312264110"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/0013-4694(83)90135-9"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2017.17060647"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2011.09.031"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2024.02.004"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbq027"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2009.12.021"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-008-1129-4"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.182.4108.177"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.2213-07.2007"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881113495117"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2017.06.023"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1159\/000343478"},{"key":"e_1_3_3_33_1","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1139\/jpn.0731","article-title":"Dysfunction in early auditory processing in major depressive disorder revealed by combined MEG and EEG","volume":"32","author":"K\u00e4hk\u00f6nen S","year":"2007","unstructured":"K\u00e4hk\u00f6nen S, Yamashita H, Ryts\u00e4l\u00e4 H, et al. (2007) Dysfunction in early auditory processing in major depressive disorder revealed by combined MEG and EEG. J Psychiatry Neurosci 32: 316\u2013322.","journal-title":"J Psychiatry Neurosci"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpsc.2018.02.002"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpsycho.2020.04.008"},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0083255"},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2010.157"},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/hup.189"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.3389\/fnhum.2022.1055685"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-69776-4"},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291716000064"},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.3988\/jcn.2012.8.1.35"},{"key":"e_1_3_3_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresbull.2007.01.007"},{"key":"e_1_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0926-6410(01)00043-X"},{"key":"e_1_3_3_45_1","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2017.176"},{"key":"e_1_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2016.05.005"},{"key":"e_1_3_3_47_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-007-0976-8"},{"key":"e_1_3_3_48_1","unstructured":"Madagascar (2011) [Television series]. United Kingdom: BBC."},{"key":"e_1_3_3_49_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2014.00003"},{"key":"e_1_3_3_50_1","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2001.0915"},{"key":"e_1_3_3_51_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.134.4.382"},{"key":"e_1_3_3_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2003.10.051"},{"key":"e_1_3_3_53_1","doi-asserted-by":"publisher","DOI":"10.1590\/1516-4446-2020-1685"},{"key":"e_1_3_3_54_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2017.16"},{"key":"e_1_3_3_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2012.06.022"},{"key":"e_1_3_3_56_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0140525X00078407"},{"key":"e_1_3_3_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinph.2007.04.026"},{"key":"e_1_3_3_58_1","doi-asserted-by":"publisher","DOI":"10.2466\/pr0.1962.10.3.799"},{"key":"e_1_3_3_59_1","doi-asserted-by":"publisher","DOI":"10.1098\/rsta.2011.0081"},{"key":"e_1_3_3_60_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-012-1214-9"},{"key":"e_1_3_3_61_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2018.18070834"},{"key":"e_1_3_3_62_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mp.4001501"},{"key":"e_1_3_3_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pscychresns.2012.07.006"},{"key":"e_1_3_3_64_1","doi-asserted-by":"publisher","DOI":"10.1177\/1550059415584704"},{"key":"e_1_3_3_65_1","doi-asserted-by":"publisher","DOI":"10.1006\/nimg.2000.0591"},{"key":"e_1_3_3_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinph.2015.10.062"},{"key":"e_1_3_3_67_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300477"},{"key":"e_1_3_3_68_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-011-2352-y"},{"key":"e_1_3_3_69_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.2006.163.11.1905"},{"key":"e_1_3_3_70_1","first-page":"10","article-title":"The definition and meaning of treatment-resistant depression","volume":"1","author":"Sackeim HA","year":"2001","unstructured":"Sackeim HA (2001) The definition and meaning of treatment-resistant depression. J Clin Psychiatry 62 Suppl 1: 10\u201317.","journal-title":"J Clin Psychiatry 62 Suppl"},{"key":"e_1_3_3_71_1","doi-asserted-by":"publisher","DOI":"10.1093\/cercor\/bhs238"},{"key":"e_1_3_3_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0013-4694(98)00017-0"},{"key":"e_1_3_3_73_1","first-page":"22","article-title":"The Mini-International Neuropsychiatric Interview (M.I.N.I.): The Development and Validation of a Structured Diagnostic Psychiatric Interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan DV","year":"1998","unstructured":"Sheehan DV (1998) The Mini-International Neuropsychiatric Interview (M.I.N.I.): The Development and Validation of a Structured Diagnostic Psychiatric Interview for DSM-IV and ICD-10. J Clin Psychiatry 59: 22\u201333.","journal-title":"J Clin Psychiatry"},{"key":"e_1_3_3_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2013.10.036"},{"key":"e_1_3_3_75_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2016.16010037"},{"key":"e_1_3_3_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2020.07.009"},{"key":"e_1_3_3_77_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-8986.2008.00748.x"},{"key":"e_1_3_3_78_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.16-13-04240.1996"},{"key":"e_1_3_3_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinph.2021.06.019"},{"key":"e_1_3_3_80_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(01)01242-2"},{"key":"e_1_3_3_81_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.57.12.1139"},{"key":"e_1_3_3_82_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2016.09.008"},{"key":"e_1_3_3_83_1","doi-asserted-by":"publisher","DOI":"10.1002\/hbm.10038"},{"key":"e_1_3_3_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3940(01)01988-7"},{"key":"e_1_3_3_85_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291723003409"},{"key":"e_1_3_3_86_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.3069-19.2020"},{"key":"e_1_3_3_87_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2020.172870"},{"key":"e_1_3_3_88_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41386-019-0317-8"},{"key":"e_1_3_3_89_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.17m11731"},{"key":"e_1_3_3_90_1","doi-asserted-by":"publisher","DOI":"10.1027\/0269-8803.21.34.147"},{"key":"e_1_3_3_91_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1023407521772"},{"key":"e_1_3_3_92_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2020.12.022"},{"key":"e_1_3_3_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2021.03.014"},{"key":"e_1_3_3_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2011.05.036"}],"container-title":["Journal of Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/02698811251319456","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/02698811251319456","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/02698811251319456","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:12:05Z","timestamp":1777507925000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/02698811251319456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,26]]},"references-count":93,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["10.1177\/02698811251319456"],"URL":"https:\/\/doi.org\/10.1177\/02698811251319456","relation":{},"ISSN":["0269-8811","1461-7285"],"issn-type":[{"value":"0269-8811","type":"print"},{"value":"1461-7285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,26]]}}}